Downregulation of ΔNp63α in keratinocytes by p14 ARF-mediated SUMO-conjugation and degradation

Cell Cycle

Volumn 8, Issue 21, 2009, Pages 3545-3551

  Vivo, Maria ^a   Di Costanzo, Antonella ^a   Fortugno, Paola ^b   Pollice, Alessandra ^a   Calabrò, Viola ^a   La Mantia, Girolama ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Keratinocyte differentiation; p14ARF; p63; Protein degradation; Sumoylation

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DELTA NP63 ALPHA; ISOPROTEIN; PROTEASOME; PROTEIN; PROTEIN P63; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SUMOYLATION; TUMOR CELL LINE; UPREGULATION;

CELL LINE, TUMOR; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DOWN-REGULATION; HELA CELLS; HUMANS; KERATINOCYTES; LEUPEPTINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 70449713412     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.21.9954     Document Type: Article

References (27)

1. Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663-673
2. Gromley A, Churchman ML, Zindy F, Sherr CJ. Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice. Proc Natl Acad Sci USA 2009; 106:6285-6290
3. Silva RL, Thornton JD, Martin AC, Rehg JE, Bertwistle D, Zindy F, Skapek SX. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBO J 2005; 24:2803-2814 (Pubitemid 41170029)
4. Pollice A, Vivo M, La Mantia G. The promiscuity of ARF interactions with the proteasome. FEBS Lett 2008; 582:3257-3262
5. Calabro V, Mansueto G, Santoro R, Gentilella A, Pollice A, Ghioni P, et al. Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family. Mol Cell Biol 2004; 24:8529-8540
6. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 2004; 18:126-131 (Pubitemid 38141780)
7. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398:708-713 (Pubitemid 29197649)
8. Ghioni P, D'Alessandra Y, Mansueto G, Jaffray E, Hay RT, La Mantia G, Guerrini L. The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. Cell Cycle 2005; 4:183-190 (Pubitemid 41038949)
9. Pollice A, Sepe M, Villella VR, Tolino F, Vivo M, Calabro V, La Mantia G. TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation. Oncogene 2007; 26:5154-5162 (Pubitemid 47206945)
10. Di Costanzo A, Festa L, Duverger O, Vivo M, Guerrini L, La Mantia G, et al. Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation. Cell Cycle 2009; 8:1185-1195
11. Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 2003; 12:2417-2430 (Pubitemid 37220407)
12. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18:6455-6461 (Pubitemid 29533249)
13. Zindy F, Williams RT, Baudino TA, Rehg JE, Skapek SX, Cleveland JL, et al. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc Natl Acad Sci USA 2003; 100:15930-15935 (Pubitemid 38021092)
14. Li Y, Peart MJ, Prives C. Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation. Mol Cell Biol 2009; 29:3953-3963
15. Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D. p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci USA 2001; 98:1817-1822 (Pubitemid 32165581)
16. Tago K, Chiocca S, Sherr CJ. Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci USA 2005; 102:7689-7694
17. Rizos H, Woodruff S, Kefford RF. p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle 2005; 4:597-603. (Pubitemid 41359789)
18. Xirodimas DP, Chisholm J, Desterro JM, Lane DP, Hay RT. p14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett 2002; 528:207-211 (Pubitemid 35258025)
19. Kuo ML, den Besten W, Thomas MC, Sherr CJ. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3. Cell Cycle 2008; 7:3378-3387
20. Xirodimas DP, Lane DP. Targeting a nucleolar SUMO protease for degradation: A mechanism by which ARF induces SUMO conjugation. Cell Cycle 2008; 7.
21. Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, et al. Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle 2004; 3:1587-1596
22. Woods YL, Xirodimas DP, Prescott AR, Sparks A, Lane DP, Saville MK. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. J Biol Chem 2004; 279:50157-50166 (Pubitemid 39577828)
23. Liu X, Liu Z, Jang SW, Ma Z, Shinmura K, Kang S, et al. Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci USA 2007; 104:9679-9684
24. Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG. Sumoylation dynamics during keratinocyte differentiation. J Cell Sci 2007; 120:125-136
25. Calabro V, Mansueto G, Parisi T, Vivo M, Calogero RA, La Mantia G. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J Biol Chem 2002; 277:2674-2681
26. Koster MI, Roop DR. p63 and epithelial appendage development. Differentiation 2004; 72:364-370
27. Su X, Cho MS, Gi YJ, Ayanga BA, Sherr CJ, Flores ER. Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 2009; 28:1904-1915